Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

Romy van der Groef,1 Pascal HP de Jong,1 Dirk Jan Hijnen,2 Christien J van der Woude,3 Jan AM van Laar,4 P Hugo M van der Kuy,5 Jan-Dietert Brugma,6 Annelieke Pasma1 1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 2Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 4Department of Internal Medicine and Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; 5Department of Clinical Phar... Mehr ...

Verfasser: van der Groef,Romy
de Jong,Pascal HP
Hijnen,Dirk Jan
van der Woude,Christien J
van Laar,Jan AM
van der Kuy,P Hugo M
Brugma,Jan-Dietert
Pasma,Annelieke
Dokumenttyp: Short Report
Erscheinungsdatum: 2023
Verlag/Hrsg.: Dove Press
Schlagwörter: Patient Preference and Adherence
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27584245
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://www.dovepress.com/impact-of-the-first-sars-cov-2-lockdown-on-adherence-to-biological-tre-peer-reviewed-fulltext-article-PPA